Protective effect of 17β-estradiol on ischemic acute renal failure through the PI3K/Akt/eNOS pathway

Kidney International

Volumn 73, Issue 3, 2008, Pages 308-317

  Satake, A ^a   Takaoka, M ^a   Nishikawa, M ^a   Yuba, M ^a   Shibata, Y ^a   Okumura, K ^a   Kitano, K ^a   Tsutsui, H ^a   Fujii, K ^a   Kobuchi, S ^a   Ohkita, M ^a   Matsumura, Y ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

17 estradiol; Acute renal failure; Akt; Nitric oxide; Phosphatidylinositol 3 kinase

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; ESTRADIOL; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; TAMOXIFEN; WORTMANNIN; ANDROSTANE DERIVATIVE; ANTIESTROGEN; ESTROGEN;

ACUTE KIDNEY FAILURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREATININE CLEARANCE; DRUG EFFECT; DRUG INHIBITION; KIDNEY BLOOD FLOW; KIDNEY ISCHEMIA; MICTURITION; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; RENAL PROTECTION; SODIUM URINE LEVEL; UREA NITROGEN BLOOD LEVEL; URINE OSMOLALITY; ANIMAL; C57BL MOUSE; DRUG ANTAGONISM; KIDNEY; KIDNEY CIRCULATION; MALE; METABOLISM; MOUSE; MOUSE MUTANT; PATHOLOGY; PHOSPHORYLATION; REPERFUSION INJURY; SPRAGUE DAWLEY RAT; TIME;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANDROSTADIENES; ANIMALS; ESTRADIOL; ESTROGEN ANTAGONISTS; ESTROGENS; KIDNEY; KIDNEY FAILURE, ACUTE; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NITRIC OXIDE SYNTHASE TYPE III; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, SPRAGUE-DAWLEY; RENAL CIRCULATION; REPERFUSION INJURY; TAMOXIFEN; TIME FACTORS;

EID: 38149041790     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/sj.ki.5002690     Document Type: Article

References (42)

1. Stampfer MJ, Colditz GA, Willett WC et al. Postmenopausal estrogen therapy and cardiovascular diseases: ten-year follow-up from the Nurse's Health Study. N Engl J Med 1991; 325: 756-762.
2. Wang M, Baker L, Tsai BM et al. Sex differences in the myocardial inflammatory response to ischemia-reperfusion injury. Am J Physiol Endocrinol Metab 2005; 288: E321-E326.
3. Zhai P, Eurell TE, Cotthaus R et al. Effect of estrogen on global myocardial ischemia-reperfusion injury in female rats. Am J Physiol Heart Circ Phisiol 2000; 279: H2766-H2775.
4. Harada H, Pavlick KP, Hines IN et al. Gender differences in physiology selected contribution: effects of gender on reduced-size liver ischemia and reperfusion injury. J Appl Physiol 2001; 91: 2816-2822.
5. Park KM, Kim JI, Ahn Y et al. Testosterone is responsible for enhanced susceptibility of males to ischemic renal injury. J Biol Chem 2004; 279: 52282-52292.
6. Müller V, Losonczy G, Heemann U et al. Sexual dimorphism in renal ischemia-reperfusion injury in rats: possible role of endothelin. Kidney Int 2002; 62: 1364-1371.
7. Edelstein CL, Ling H, Schrier RW. The nature of renal cell injury. Kidney Int 1997; 51: 1341-1351.
8. Conger JD, Weil JV. Abnormal vascular function following ischemia-reperfusion injury. J Investig Med 1995; 43: 431-442.
9. Molitoris BA, Sutton TA. Endothelial injury and dysfunction: role in the extension phase of acute renal failure. Kidney Int 2004; 66: 496-499.
10. Park KM, Byun JY, Kramers C et al. Inducible nitric-oxide synthase is an important contributor to prolonged protective effects of ischemic preconditioning in the mouse kidney. J Biol Chem 2003; 278: 27256-27266.
11. Schramm L, Heidbreder E, Schmitt A et al. Role of L-arginine-derived NO in ischemic acute renal failure in the rat. Renal Failure 1994; 16: 555-569.
12. Chintala MS, Chiu PJS, Vemulapalli S et al. Inhibition of endothelial derived relaxing factor (EDRF) aggravates ischemic acute renal failure in anesthetized rats. Naunyn-Schmiedeberg's Arch Pharmacol 1993; 348: 305-310.
13. Matsumura Y, Nishiura M, Deguchi S et al. Protective effect of FK409, a spontaneous nitric oxide releaser, on ischemic acute renal failure in rats. J Pharmacol Exp Ther 1998; 287: 1084-1091.
14. Shibata Y, Takaoka M, Maekawa D et al. Involvement of nitric oxide in the suppressive effect of 17β-estradiol on endothelin-1 overproduction in ischemic acute renal failure. J Cardiovasc Pharmacol 2004; 44: S459-S461.
15. Stirone C, Boroujerdi A, Duckles SP et al. Estrogen receptor activation of phosphoinositide-3 kinase, Akt, and nitric oxide signaling in cerebral blood vessels: rapid and long-term effects. Mol Parmacol 2005; 67: 105-113.
16. Simoncini T, Hafezi-Moghadam A, Brazil DP et al. Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase. Nature 2000; 407: 538-541.
17. Hisamoto K, Ohmichi M, Kurachi H et al. Estrogen induces the Akt-dependent activation of endothelial nitric-oxide synthase in vascular endothelial cells. J Biol Chem 2001; 276: 3459-3467.
18. Haynes MP, Sinha D, Russell KS et al. Membrane estrogen receptor engagement activates endothelial nitric oxide synthase via the PI3-kinase-Akt pathway in human endothelial cells. Circ Res 2000; 87: 677-682.
19. Chambliss KL, Shaul PW. Estrogen modulation of endothelial nitric oxide synthase. Endocr Rev 2002; 23: 665-686.
20. Hishikawa K, Nakaki T, Marumo T et al. Up-regulation of nitric oxide synthase by estradiol in human aortic endothelial cells. FEBS Lett 1995; 360: 291-293.
21. Hayashi T, Yamada K, Esaki T et al. Estrogen increases endothelial nitric oxide by a receptor-mediated system. Biochem Biophys Res Commun 1995; 214: 847-855.
22. MacRitchie AN, Jun SS, Chen Z et al. Estrogen upregulates endothelial nitric oxide synthase gene expression in fetal pulmonary artery endothelium. Circ Res 1997; 81: 355-362.
23. Nuedling S, Karas RH, Mendelsohn ME et al. Activation of estrogen receptor β is a prerequisite for estrogen-dependent upregulation of nitric oxide synthases in neonatal rat cardiac myocytes. FEBS Lett 2001; 502: 103-108.
24. Chen Z, Yuhanna IS, Galcheva-Gargova Z et al. Estrogen receptor a mediates the non-genomic activation of endothelial nitric oxide synthase by estrogen. J Clin Invest 1999; 103: 401-406.
25. Linas S, Whittenburg D, Repine JE. Nitric oxide prevents neutrophil-mediated acute renal failure. Am J Physiol Renal Physiol 1997; 272: F48-F54.
26. Kurata H, Takaoka M, Kubo Y et al. Protective effect of nitric oxide on ischemia/reperfusion-induced renal injury and endothelin-1 overproduction. Eur J Pharmacol 2005; 517: 232-239.
27. Wilhelm SM, Simonson MS, Robinson AV et al. Endothelin up-regulation and localization following renal ischemia and reperfusion. Kidney Int 1999; 55: 1011-1018.
28. Matsumura Y, Kuro T, Kobayashi Y et al. Protective effect of SM-19712, a novel and potent endothelin converting enzyme inhibitor, on ischemic acute renal failure in rats. Jpn J pharmacol 2000; 84: 16-24.
29. Takaoka M, Yuba M, Fujii T et al. Oestrogen protects against ischemic acute renal failure in rats by suppressing renal endothelin-1 overproduction. Clin Sci 2002; 103: 434S-437S.
30. Nakajima A, Ueda K, Takaoka M et al. Opposite effects of pre- and postischemic treatments with nitric oxide donor on ischemia/reperfusion-induced renal injury. J Pharmacol Exp Ther 2006; 316: 1038-1046.
31. Linas SL, Shanley PF, Whittenburg D et al. Neutrophils accentuate ischemia-reperfusion injury in isolate perfused rat kidneys. Am J Physiol Renal Physiol 1988; 255: F728-F735.
32. Linas SL, Whittenburg D, Parsons PE et al. Mild renal ischemia activates primed neutrophils to acute renal failure. Kidney Int 1992; 42: 610-616.
33. Mehta RL, Pascual MT, Gruta CG et al. Reflecting predictive models in critically ill patients with acute renal failure. J Am Soc Nephrol 2002; 13: 1350-1357.
34. Chertow GM, Lazarus JM, Paganini EP et al. Predictors of mortality and the provision of dialysis in patients with acute tubular necrosis. J Am Soc Nephrol 1998; 9: 692-698.
35. Zeier M, Döhler B, Opelz G et al. The effect of donor gender on graft survival. J Am Soc Nephrol 2002; 13: 2570-2576.
36. Jain A, Reyes J, Kashyap R et al. Long-term survival after liver transplantation in 4,000 consecutive patients at a single center. Ann Surg 2000; 232: 490-500.
37. Mulroney SE, Woda C, Johnson M et al. Gender differences in renal growth and function after uninephrectomy in adult rats. Kidney Int 1999; 56: 944-953.
38. Oestreicher EM, Guo C, Seely EW et al. Estradiol increases proteinuria and angiotensin II type 1 receptor in kidneys of rats receiving L-NAME and angiotensin II. Kidney Int 2006; 70: 1759-1768.
39. Joles JA, van Goor H, Koomans HA. Estrogen induces glomerulosclerosis in analbuminemic rats. Kidney Int 1998; 53: 862-868.
40. Antus B, Hamar P, Kokeny G et al. Estradiol is nephroprotective in the rat remnant kidney. Nephrol Dial Transplant 2003; 18: 54-61.
41. Maric C, Sandberg K, Hinojosa-Laborde C. Glomerulosclerosis and tubulointerstitial fibrosis are attenuated with 17beta-estradiol in the aging Dahl salt sensitive rat. J Am Soc Nephrol 2004; 15: 1546-1556.
42. Caramelo C, Espinosa G, Manzarbeitia F et al. Role of endothelium-related mechanisms in the pathophysiology of renal ischemia/reperfusion in normal rabbits. Circ Res 1996; 79: 1031-1038.